https://t.co/uUYabIrF2A
We have advertised for a Clinical Research Fellow to work in our Clinical Academic Team @wpp_wiph@NHSBartsHealth
We run a number of studies in precision prevention of Women’s cancers
https://t.co/QYL5KlIDru
Come and join our team
Please RT
Delighted to share our paper just out in Jama Oncology!
Overall, undergoing risk reducing mastectomy (RRM) was found to be cost-effective for women aged 30 to 55 years with a lifetime breast cancer risk of at least 35%.
@ProfManchanda
https://t.co/n57dYoPSPy
https://t.co/TQO8Li0oVV
Great to see our paper out in JAMA Oncology re what should be the Breast Cancer risk thresholds at which we offer Risk Reducing Mastectomy
RRM is cost-effective for women with a lifetime BC risk >=35%.
@ProfManchanda speaks about HR-QOL after RRH in women with #Lynchsyndrome and BRCA-DIRECT evaluation, Dr Sam Oxley on the cost-effective lifetime risk threshold for risk-reducing options for womb cancer, our poster on improving questionnaire response rates in PROTECTOR #BGCS2025
@ProfManchanda, Dr Jacqueline Sia, Dr Jyotsna Pundir and @GKurzer giving talks on population-based genetic testing, early salpingectomy and delayed oophorectomy, fertility preservation in women with cancer, and the role of the CNS in genomics respectively on BGCS Day 3 #BGCS2025
Congratulations to Sam Oxley on presenting his work from the PRESCORES study at #ESGO2025 - Health-related quality of life after risk-reducing hysterectomy in women with Lynch syndrome
These utility scores will be useful in informing clinical practice.
@ProfManchanda
Thank you to the amazing members of the public who attended our workshop for PROTECT-C on Friday! 🙏
We are so grateful for the input, comments, and suggestions to improve the PROTECT-C study!
More about PROTECT-C: https://t.co/MlHVArfp86
@ProfManchanda@QMUL_WIPH@QMUL_CCSPED
@ProfManchanda said: “The concept of broadening genetic testing for cancer genes across the entire population could prevent thousands more cancers than any current strategy, saving many lives.”
https://t.co/txE2ZNnpwo
We are excited to announce the launch of our Women's Precision Prevention website! Our team was founded by @ProfManchanda in 2015.
Find out more about our research work, our team, our clinical service and news and events!
https://t.co/4TjrlMWvCe
Delighted to attend & speak at the launch event for the NHS Jewish BRCA testing programme, organised by Jnetics and Chai at House of Lords. Absolutely thrilled that 16 yrs of my research into population testing has come to fruition.
The PRESCORES study needs your help to provide feedback about our surveys! Our PhD student, Sam, would greatly appreciate your help 😊
Please see the here or link in our bio to register your interest!
https://t.co/HOYOU1AaYQ
#womensprecisionprevention#wpp#prescores
At the age of 26, Laura Brennan passed away from #CervicalCancer, a vaccine-preventable disease.
"The HPV vaccine saves lives. It could have saved hers." Bernie and Larry narrate the heartbreaking loss of their daughter.
This is their story 👇